or Try an Advanced Search...

    Technical Analysis for ANRO - Alto Neuroscience, Inc.

    Grade Last Price % Change Price Change
    F 4.27 -4.69% -0.21
    ANRO closed down 4.69 percent on Wednesday, November 20, 2024, on 40 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ANRO trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    Crossed Above 20 DMA Bullish -4.69%
    NR7 Range Contraction -4.69%
    Narrow Range Bar Range Contraction -4.69%
    20 DMA Resistance Bearish -7.17%
    Narrow Range Bar Range Contraction -7.17%
    Wide Bands Range Expansion -7.17%
    NR7 Range Contraction -5.53%
    Narrow Range Bar Range Contraction -5.53%
    Wide Bands Range Expansion -5.53%
    Older End-of-Day Signals for ANRO ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Support about 17 hours ago
    Fell Below 20 DMA about 17 hours ago
    Down 5% about 18 hours ago
    60 Minute Opening Range Breakdown about 21 hours ago
    Down 3% about 22 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ANRO Chart by TradingView
    Basic chart:

    Profile

    Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Alto's Precision Psychiatry Platform™ measures brain biomarkers by analyzing EEG activity, neurocognitive assessments, wearable data, and other factors to better identify which patients are more likely to respond to Alto product candidates. Alto’s clinical-stage pipeline includes novel drug candidates in depression, PTSD, schizophrenia, and other mental health conditions.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Neuroscience Schizophrenia Biomarkers Depression Neurophysiology Electroencephalography Post Traumatic Stress Disorder Neurocognition Ptsd

    Is ANRO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 13 Alto Neuroscience GAAP EPS of -$0.62
    Nov 12 Alto Neuroscience Reports Third Quarter 2024 Financial Results and Recent Business Highlights
    Oct 26 Notable analyst calls this week: McDonald's, Apple and Enphase Energy among top picks
    Oct 24 Wedbush downgrades Alto Neuroscience to Neutral following ALTO-100 readout
    Oct 23 Neuropsychiatry-Focused Alto Neuroscience's Mid-Stage Depression Trial Disappoints, Analyst Notes Failure Raises Concerns About Platform
    Oct 23 Alto Neuroscience stock crashes amid failed study and Wedbush downgrade
    Oct 23 Alto hits new low as depression drug flunks key test
    Oct 23 Alto’s Phase IIb study of ALTO-100 for MDD fails to meet primary endpoint
    Oct 23 Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
    Oct 22 Alto Neuroscience stock craters 57% post-market on failed study
    See more ANRO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 24.0
    52 Week Low 3.61
    Average Volume 882,846
    200-Day Moving Average 12.21
    50-Day Moving Average 9.13
    20-Day Moving Average 4.23
    10-Day Moving Average 4.45
    Average True Range 0.63
    RSI (14) 31.51
    ADX 38.85
    +DI 17.36
    -DI 36.80
    Chandelier Exit (Long, 3 ATRs) 12.82
    Chandelier Exit (Short, 3 ATRs) 5.49
    Upper Bollinger Bands 4.86
    Lower Bollinger Band 3.60
    Percent B (%b) 0.53
    BandWidth 29.78
    MACD Line -1.36
    MACD Signal Line -1.65
    MACD Histogram 0.2917
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.79
    Resistance 3 (R3) 4.82 4.68 4.70
    Resistance 2 (R2) 4.68 4.54 4.66 4.67
    Resistance 1 (R1) 4.47 4.46 4.40 4.44 4.64
    Pivot Point 4.33 4.33 4.30 4.32 4.33
    Support 1 (S1) 4.13 4.20 4.06 4.10 3.90
    Support 2 (S2) 3.99 4.12 3.97 3.87
    Support 3 (S3) 3.78 3.99 3.84
    Support 4 (S4) 3.75